Standard BioTools Inc. (LAB)
2.00
-0.06 (-2.91%)
At close: Jan 14, 2025, 3:59 PM
2.01
0.25%
After-hours Jan 14, 2025, 04:25 PM EST
undefined% (undefined)
| Bid | 1.91 |
| Market Cap | 746.38M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.87 |
| PE Ratio (ttm) | -2.3 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.01 |
| Volume | 1,843,025 |
| Avg. Volume (20D) | 1,885,577 |
| Open | 2.05 |
| Previous Close | 2.06 |
| Day's Range | 1.93 - 2.05 |
| 52-Week Range | 1.21 - 3.04 |
| Beta | undefined |
About LAB
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immu...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Feb 10, 2011
Employees 534
Stock Exchange NASDAQ
Ticker Symbol LAB
Website https://www.fluidigm.com
Analyst Forecast
According to 2 analyst ratings, the average rating for LAB stock is "Buy." The 12-month stock price forecast is $2.88, which is an increase of 43.64% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Standard BioTools Inc. is scheduled to release its earnings on Feb 26, 2025,
during market hours.
Analysts project revenue of $47.03M, reflecting a 66.84% YoY growth and earnings per share of -0.08, making a -68.00% decrease YoY.
Analysts project revenue of $47.03M, reflecting a 66.84% YoY growth and earnings per share of -0.08, making a -68.00% decrease YoY.
1 day ago ·
Source
+26.38%
Standard BioTools shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago ·
Source
-36.61%
Standard BioTools shares are trading lower after the company reported worse-than-expected Q2 financial results and cut FY24 revenue guidance below estimates. The company announced CFO Jeffery Black will resign.
